Anthropic and OpenAI Join a $500M Plan to End the Common Cold

Backers including Stripe, Anthropic, and the OpenAI Foundation have founded Intercept, a $500 million nonprofit that hopes to leave routine illnesses like colds and flu "in the past" — with the money going toward tools that prevent respiratory viruses and technologies for cleaner indoor air.

In brief

• It will fund vaccines, sprays, and pills that block dozens of respiratory viruses, plus air-cleaning tech for offices and schools.
• Intercept says routine infections cost each person 15–25 days a year — about $600 billion in lost global productivity.
• The $500M isn't for bringing products to market; it's to carry early research to the point where pharma and investors take over the expensive final stage.

Our take

We're used to ambitious medical missions in this AI-powered era of science — but this one hits close to home for everyone. What's striking is who's writing the checks: deep-pocketed AI giants and their employees are funding the hard "middle stage" that pharma tends to skip as too risky. That's the real bet here — putting capital into the most clogged part of solving a universal problem.

Kaynak: Intercept